Tuesday, May 17, 2022

Sierra Oncology, Inc. (SRRA) Stock on a Roll, Here’s Why

Sierra Oncology, Inc. (SRRA), a late-stage drug development company, closed Tuesday’s regular trading session at $39.52 after gaining an increase of 3.10% during the day. In the premarket, SRRA has surged by 36.26% and as a result, was trading at $53.85 at the time of the writing.


Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .

Sponsored


GSK to Acquire SRRA

The exuberant performance from SRRA followed the agreement of acquisition between GSK and SRRA. Hours ago, GlaxoSmithKline plc and Sierra Oncology, Inc announced to have entered into the agreement. Under the agreement, GlaxoSmith would acquire Sierra for a price of $55 per share of common stock in the cash which represents an equity value of $1.9 billion approximately.

Healthcare Sector Suffering


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


In the wake of current turmoil on geopolitical and economic fronts, the healthcare sector is also facing ramifications. Since the last couple of days, healthcare stocks were depicting dismal performance. Consumer prices have taken a hit as a result of constantly rising inflationary pressure, which in turn has had an indirect impact on the more stable sectors, like healthcare.

Institutional Investment in SRRA

On the investment front, several large investors have been buying the shares of SRRA recently. Elmwood Wealth Management Inc. has bought a stake, which is valued at about $25,000. JPMorgan Chase & Co. saw an increase of more than 1,200.0% in its stake in Sierra, and as a result, it now holds 1300 shares of the company which are accumulatively valued at $28,000. Another asset management platform, Acadian LLC, bought a stake valued at about $79,000 in Sierra. Several other investors have also set their eyes on investing in SRRA.

Final Remarks

Looking ahead, the horizon appears to be clear for SRRA in near future. The stock had an excellent 12 months period, and the recent developments suggest that the same would be the case so in the future.

Latest news

A Few Bright Spots in Tesla Inc. (TSLA)

Tesla's (TSLA) Shanghai facility ceased operations on Monday owing to material shortages, according to Reuters. Furthermore, demand for Tesla electric vehicles decreased drastically in...

A Closer Look at DocuSign Inc.’s (DOCU) Growth Curve

DocuSign Inc. (NASDAQ: DOCU), a software firm that creates an electronic signature and verification solutions, is presently trading more than 70% below its 52-week...

One Of The Good Ones: Enphase Energy Inc. (ENPH)

Enphase Energy, Inc. (NASDAQ: ENPH), a maker of inverters, released its first-quarter 2022 results. Enphase set a new sales record and outperformed Wall Street...

Riding the Trend or Protecting Profits | AT&T Inc. (T)

AT&T Inc. (NYSE: T), a telecommunications service provider, released its first-quarter earnings last week. The firm claimed a record number of new communication subscribers,...

Related news

A Few Bright Spots in Tesla Inc. (TSLA)

Tesla's (TSLA) Shanghai facility ceased operations on Monday owing to material shortages, according to Reuters. Furthermore, demand for Tesla electric vehicles decreased drastically in...

A Closer Look at DocuSign Inc.’s (DOCU) Growth Curve

DocuSign Inc. (NASDAQ: DOCU), a software firm that creates an electronic signature and verification solutions, is presently trading more than 70% below its 52-week...

One Of The Good Ones: Enphase Energy Inc. (ENPH)

Enphase Energy, Inc. (NASDAQ: ENPH), a maker of inverters, released its first-quarter 2022 results. Enphase set a new sales record and outperformed Wall Street...

Riding the Trend or Protecting Profits | AT&T Inc. (T)

AT&T Inc. (NYSE: T), a telecommunications service provider, released its first-quarter earnings last week. The firm claimed a record number of new communication subscribers,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

1745

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam